Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3368]

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers 

ASH 2025: ‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukaemia

ASH 2025: ‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukaemia

ASH 2025: New findings support a chemo-free approach for treating Ph+ ALL

ASH 2025: New findings support a chemo-free approach for treating Ph+ ALL

ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome

ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome

Researchers develop ultrasensitive method to detect low-frequency cancer mutations

Researchers develop ultrasensitive method to detect low-frequency cancer mutations

Cancer loses its sense of time to avoid stress responses

Cancer loses its sense of time to avoid stress responses

ASH 2025: Home-based monitoring could transform care for patients receiving T-cell redirecting therapies

ASH 2025: Home-based monitoring could transform care for patients receiving T-cell redirecting therapies

ASH 2025: Developed antibody boosts immune response against blood cancers and solid cancers

ASH 2025: Developed antibody boosts immune response against blood cancers and solid cancers

Team discovers how to target ‘undruggable’ protein that fuels aggressive leukaemia

Team discovers how to target ‘undruggable’ protein that fuels aggressive leukaemia

$ASH 2025: Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma$

ASH 2025: Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or...

More from ecancer